Difference between revisions of "Template:Current week ecosystem agenda"
From Bioblast
Tindle Lisa (talk | contribs) |
Tindle Lisa (talk | contribs) |
||
Line 38: | Line 38: | ||
:::: '''»[[MiPNet27.06 BEC tutorial-Living_Communications pmF |BEC tutorial-Living_Communications ''pmF'']]«''' Prague, Sep 22 | :::: '''»[[MiPNet27.06 BEC tutorial-Living_Communications pmF |BEC tutorial-Living_Communications ''pmF'']]«''' Prague, Sep 22 | ||
:::: '''»[[EMC2022 Prague CZ]]«''' Sep 22-26 | :::: '''»[[EMC2022 Prague CZ]]«''' Sep 22-26 | ||
:{| | |||
| width="100" align="center" | [[File:O2k-brief.png|45px|link=http://wiki.oroboros.at/index.php/O2k-brief|O2k-brief repository]] | |||
|''' A ketogenic diet is a promising approach towards alleviating mitochondrial dysfunction in MELAS disease.''' <br> | |||
* Belal S, Goudenège D, Bocca C, Dumont F, Chao De La Barca JM, Desquiret-Dumas V, Gueguen N, Geffroy G, Benyahia R, Kane S, Khiati S, Bris C, Aranyi T, Stockholm D, Inisan A, Renaud A, Barth M, Simard G, Reynier P, Letournel F, Lenaers G, Bonneau D, Chevrollier A, Procaccio V (2022) Glutamate-induced deregulation of krebs cycle in mitochondrial encephalopathy lactic acidosis syndrome stroke-like episodes (MELAS) syndrome is alleviated by ketone body exposure. [[Belal 2022 Biomedicines|»Bioblast link«]]<br> | |||
:from the O2k-Network »[[FR Angers Gueguen N]]« | |||
|} | |||
---- | ---- | ||
Revision as of 13:19, 22 September 2022
- Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. - »More details
- -» A future for Ukraine is the future of its science
2022 Week 38
- Sep-19 Mo
World Mitochondrial Disease Week – Sep 18-24
World Mitochondrial Disease Week raises awareness of mitochondrial disease through educational, fundraising and advocacy activities.
See what is happening near you - »https://mitochondrialdiseaseweek.org/events/
- Sep-20 Tu
Bioenerg Commun 2022.4: A review on the current landscape of mitochondrial disease drug development
- Åsander Frostner E, Simón Serrano S, Chamkha I, Donnelly E, Elmér E, Hansson MJ (2022) Towards a treatment for mitochondrial disease: current compounds in clinical development. https://doi.org/10.26124/bec:2022-0004
- from the O2k-Network »SE Lund Elmer E«
- Sep-21 We
"By tracing the carbon flow of the nutrients glucose and glutamine in cells derived from patients with different genetically defined causes of primary mitochondrial diseases (PMD), we identified several key metabolic changes supporting the major importance of an NAD+/NADH imbalance in PMD."
- Adant I, Bird M, Decru B, Windmolders P, Wallays M, de Witte P, Rymen D, Witters P, Vermeersch P, Cassiman D, Ghesquière B (2022) Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction. »Bioblast link«
- from the O2k-Network »BE Leuven Vermeersch P«
- Sep-22 Th
- »BEC tutorial-Living_Communications pmF« Prague, Sep 22
- »EMC2022 Prague CZ« Sep 22-26
A ketogenic diet is a promising approach towards alleviating mitochondrial dysfunction in MELAS disease.
- Belal S, Goudenège D, Bocca C, Dumont F, Chao De La Barca JM, Desquiret-Dumas V, Gueguen N, Geffroy G, Benyahia R, Kane S, Khiati S, Bris C, Aranyi T, Stockholm D, Inisan A, Renaud A, Barth M, Simard G, Reynier P, Letournel F, Lenaers G, Bonneau D, Chevrollier A, Procaccio V (2022) Glutamate-induced deregulation of krebs cycle in mitochondrial encephalopathy lactic acidosis syndrome stroke-like episodes (MELAS) syndrome is alleviated by ketone body exposure. »Bioblast link«
- from the O2k-Network »FR Angers Gueguen N«
- Belal S, Goudenège D, Bocca C, Dumont F, Chao De La Barca JM, Desquiret-Dumas V, Gueguen N, Geffroy G, Benyahia R, Kane S, Khiati S, Bris C, Aranyi T, Stockholm D, Inisan A, Renaud A, Barth M, Simard G, Reynier P, Letournel F, Lenaers G, Bonneau D, Chevrollier A, Procaccio V (2022) Glutamate-induced deregulation of krebs cycle in mitochondrial encephalopathy lactic acidosis syndrome stroke-like episodes (MELAS) syndrome is alleviated by ketone body exposure. »Bioblast link«
- Sep-23 Fr
Investigating the cause of late-onset SLC25A26-related mitochondrial disease
- Schober FA, Tang JX, Sergeant K, Moedas MF, Zierz CM, Moore D, Smith C, Lewis D, Guha N, Hopton S, Falkous G, Lam A, Pyle A, Poulton J, Gorman GS, Taylor RW, Freyer C, Wredenberg A (2022) Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease. »Bioblast link«
- from the O2k-Network »BE Leuven Vermeersch P«
- Sep-24 Sa
- Sep-25 Su
- -» 12:10 (GMT+2): Erich Gnaiger presenting at EMC2022 Prague CZ - Body mass excess, muscle mass, obesity and mitochondrial fitness
- -» 12:10 (GMT+2): Erich Gnaiger presenting at EMC2022 Prague CZ - Body mass excess, muscle mass, obesity and mitochondrial fitness